A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.

Cadmium hydroxide

CAS21041-95-2
EC244-168-5

List details

Basic info

Status Opinion Adopted
Submitter Sweden
Regulatory programme
  • Other substance
CLP Annex VI Index Number
  • 048-013-00-0
ATP number and date ATP10 - (04/05/2017), 01/12/2018
Link to ATP

Classification

Harmonised classification at the time of the proposal
  • Acute Tox. 4*, H302
  • Acute Tox. 4*, H312
  • Acute Tox. 4*, H332
  • Aquatic Acute 1, H400
  • Aquatic Chronic 1, H410
Proposed harmonised classification by the dossier submitter
  • Acute Tox. 4, H302
  • Acute Tox. 4, H312
  • Acute Tox. 4, H332
  • Muta. 1B, H340
  • Carc. 1B, H350
  • STOT RE 1, H372
  • Aquatic Acute 1, H400
  • Aquatic Chronic 1, H410
Hazard classes open for commenting Germ cell mutagenicity Carcinogenicity Specific target organ toxicity — repeated exposure

Intention timeline

Date of intention 2013-09-27
Submitted for accordance check 2013-12-19
Final submission date 2015-02-04
Start of consultation 2015-03-27
Deadline for commenting 2015-05-11
Date of opinion 2015-12-04
Legal deadline for opinion adoption 2016-08-03

Documents

CLH report
Comments received
Public consultations - received attachments
RAC opinion
Background document external link [echa.europa.eu]

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

April 4, 2019
  • Regulatory programme: Other substanceChemical registered under REACH
This version
Add the related substance to your watchlist to monitor this regulatory record.